WPI 2266 (Acitretin 25 mg)
Pill imprint WPI 2266 has been identified as Acitretin 25 mg.
Acitretin is used in the treatment of psoriasis; psoriatic arthritis; pityriasis rubra pilaris and belongs to the drug class antipsoriatics. Not for use in pregnancy. Acitretin 25 mg is not a controlled substance under the Controlled Substance Act (CSA).
Acitretin
- Imprint:
- WPI 2266
- Strength:
- 25 mg
- Color:
- Brown & Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antipsoriatics
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Actavis Pharma, Inc.
More about acitretin
Consumer resources
- Other brands: Soriatane, Soriatane CK
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
